Nordhealth AS (NORDH.OL)

NOK 34.8

(0.0%)

EBITDA Summary of Nordhealth AS

Nordhealth AS's latest annual EBITDA in 2023 was -659 Thousand EUR , up 87.81% from previous year.
Nordhealth AS's latest quarterly EBITDA in 2024 Q2 was 1.2 Million EUR , up 244.29% from previous quarter.
Nordhealth AS reported an annual EBITDA of -5.97 Million EUR in 2022, down -1365.58% from previous year.
Nordhealth AS reported an annual EBITDA of -222 Thousand EUR in 2021, down -110.38% from previous year.
Nordhealth AS reported a quarterly EBITDA of 1.2 Million EUR for 2024 Q2, up 244.29% from previous quarter.
Nordhealth AS reported a quarterly EBITDA of -927 Thousand EUR for 2023 Q1, up 53.74% from previous quarter.

Annual EBITDA Chart of Nordhealth AS (2023 - 2019)

Historical Annual EBITDA of Nordhealth AS (2023 - 2019)

Year	EBITDA	EBITDA Growth
2023	-659 Thousand EUR	87.81%
2022	-5.97 Million EUR	-1365.58%
2021	-222 Thousand EUR	-110.38%
2020	3.55 Million EUR	2468.69%
2019	-150.04 Thousand EUR	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	350 Thousand EUR	148.81%
2024 Q2	1.2 Million EUR	244.29%
2023 Q1	-927 Thousand EUR	53.74%
2023 FY	- EUR	87.81%
2023 Q4	-717 Thousand EUR	-181.29%
2023 Q3	882 Thousand EUR	748.08%
2023 Q2	104 Thousand EUR	111.22%
2022 Q2	-1.31 Million EUR	-21.84%
2022 Q1	-1.07 Million EUR	-26.59%
2022 FY	- EUR	-1365.58%
2022 Q4	-2 Million EUR	-97.24%
2022 Q3	-1.01 Million EUR	22.5%
2021 Q2	-1.22 Million NOK	0.0%
2021 FY	- EUR	-110.38%
2021 Q4	-850 Thousand EUR	-198.49%
2021 Q3	863 Thousand NOK	170.56%
2020 FY	- EUR	0.0%
2020 Q3	965 Thousand NOK	0.0%
2020 Q4	1.28 Million EUR	33.37%

Peer EBITDA Comparison of Nordhealth AS

Name	EBITDA	EBITDA Difference
Carasent ASA	2.91 Million NOK	122.638%
CodeLab Capital AS	61.49 Million NOK	101.072%